Want to join the conversation?
$ZUMZ's 3Q16 net sales are expected to be $209-213MM, resulting in diluted EPS of approx. $0.21-0.26. This guidance is based upon an anticipated comparable sales range of negative 2% to 0% for 3Q16. The company currently intends to open approx. 29 new stores in FY16, including up to 6 stores in Canada and 7 stores in Europe.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.